- Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program Milestones
- Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
- Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full Year 2023 Financial Results
- Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio Update
- Design Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portfolio Update in Early 2024
- Design Therapeutics Provides Pipeline Update and Reports Second Quarter 2023 Financial Results
- Design Therapeutics Reports Initial Results from Phase 1 Multiple-Ascending Dose Study of DT-216 for the Treatment of Friedrich Ataxia
More ▼
Key statistics
On Tuesday, Design Therapeutics Inc (DSGN:NSQ) closed at 3.20, 64.95% above the 52 week low of 1.94 set on Aug 22, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.25 |
---|---|
High | 3.40 |
Low | 3.17 |
Bid | 2.22 |
Offer | 5.11 |
Previous close | 3.20 |
Average volume | 199.28k |
---|---|
Shares outstanding | 56.50m |
Free float | 35.85m |
P/E (TTM) | -- |
Market cap | 180.78m USD |
EPS (TTM) | -1.05 USD |
Data delayed at least 15 minutes, as of Jul 02 2024 21:00 BST.
More ▼